Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53.4M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
7.37M
-
Shares change
-
-109K
-
Total reported value, excl. options
-
$23.5M
-
Value change
-
-$277K
-
Number of buys
-
13
-
Number of sells
-
-21
-
Price
-
$3.19
Significant Holders of scPharmaceuticals Inc. - Common Stock (SCPH) as of Q2 2019
38 filings reported holding SCPH - scPharmaceuticals Inc. - Common Stock as of Q2 2019.
scPharmaceuticals Inc. - Common Stock (SCPH) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.37M shares
of 53.4M outstanding shares and own 13.81% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3.41M shares), RA CAPITAL MANAGEMENT, LLC (3.25M shares), Eversept Partners, LP (174K shares), VANGUARD GROUP INC (89K shares), NORTHERN TRUST CORP (66.6K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (61.5K shares), Alambic Investment Management, L.P. (59.8K shares), RENAISSANCE TECHNOLOGIES LLC (45.5K shares), JACOBS LEVY EQUITY MANAGEMENT, INC (36.9K shares), and MILLENNIUM MANAGEMENT LLC (33.8K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.